November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LAS VEGAS — A repuncturable vascular ...

In patients with common femoral artery disease, balloon angioplasty plus stenting if needed achieves acceptable restenosis and target lesion revascularization (TLR) rates at 1 year. The results render ...

Cordis, a unit of Johnson & Johnson ($JNJ) is seeking an expanded indication for its SMART self-expanding stent, and the device performed well in patients with ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A peripheral stent was safe and effective for treatment of common femoral artery lesions at 12 ...

The FDA approved W.L. Gore’s third-generation, self-expanding stent for the treatment of peripheral artery disease. CE-marked in 2011, the device is designed to work better with natural knee movement ...

IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, ...

LEIPZIG, GERMANY—What’s the best course of corrective action for obstructive lesions of the common femoral artery (CFA) caused by PAD? At LINC 2020, two experts took to the main stage to debate this ...

Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the ...

Diagnosing coronary heart disease has been accomplished since the 1960s by coronary angiography. During the process, involving guiding a catheter tube through the body to the heart, contrast dye is ...